NuGene International, Inc. filed its 10-12G on Jul 11, 2022 for the period ending Dec 31, 2021. In this report its auditor, Olayinka Oyebola & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0139 USD | +15.83% | -0.71% | +16.81% |
05-06 | Livento Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-01 | Livento Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+16.81% | 11.55M | |
+13.19% | 8.12B | |
-9.29% | 5.9B | |
+6.69% | 5.59B | |
+4.98% | 4.57B | |
+9.47% | 4.23B | |
+11.29% | 3.65B | |
+13.87% | 3.15B | |
-9.15% | 2.86B | |
-27.55% | 2.22B |
- Stock Market
- Equities
- NUGN Stock
- News Livento Group, Inc.
- NuGene International, Inc. Auditor Raises 'Going Concern' Doubt